Marimed (MRMD) Equity Ratio (2011 - 2026)

Marimed (MRMD) has 16 years of Equity Ratio data on file, last reported at 0.23 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.23, down 16.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.23 (down 16.84% YoY), and the FY2025 annual result was 0.25, down 12.72% from the prior year.
• Equity Ratio eased to 0.23 in Q1 2026 per MRMD's latest filing, from 0.25 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.43 in Q2 2023 and troughed at 0.23 in Q1 2026.
• A 5-year average of 0.32 and a median of 0.32 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio jumped 94.75% in 2022, then declined 24.42% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.38 in 2022, then retreated by 6.72% to 0.35 in 2023, then dropped by 19.47% to 0.28 in 2024, then declined by 12.72% to 0.25 in 2025, then slipped by 6.35% to 0.23 in 2026.
• Business Quant data shows MRMD's Equity Ratio at 0.23 in Q1 2026, 0.25 in Q4 2025, and 0.26 in Q3 2025.